Here we affirm the pharmacological potential of NMDA receptor channel blockers for obesity treatment (Extended Data Fig
For instance, they can create meal plans to ensure youre getting enough protein around 0.55 grams per pound of body weight (thats about 82 grams a day for someone who weighs 150 pounds)
( 10.2337/dc20-1473) [DOI] [PMC free article] [PubMed] [Google Scholar] 18.Lingvay I, Hansen T, MacUra S, Marre M, Nauck MA, De La Rosa R, Woo V, Yildirim E, Wilding J
Traditional GLP-1 weight-loss treatments (such as Saxenda , Ozempic , or Mounjaro ) are typically approved for people with a BMI over 30, or over 27 with medical conditions such as diabetes or high blood pressure
Furthermore, GLP-1 receptor agonists demonstrate pleiotropic effects, including significant improvements in glycemic control and lipid metabolism parameters 8,9
1,2 Those figures come from separate trials in different populations, and retatrutide isnt legally available in the UK